Shopping Cart 0
Cart Subtotal
USD 0

University of Pittsburgh - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

University of Pittsburgh (Pitt) is an educational research institute that offers undergraduate, graduate and professional programs. The institute provides academic courses in different fields such as business, information sciences, health and rehabilitation, information sciences, engineering, environmental and occupational health, epidemiology, nursing, bioinformatics, biological sciences, pharmacy, arts, social sciences, law, medicine, public and international affairs. It conducts research in the areas such as aging, bioengineering, computer modeling, drug discovery, global health, humanities, international studies, and others. Pitt collaborates with universities for its research activities. The institute is member of the Association of American Universities. Pitt is headquartered in Pittsburgh, Pennsylvania, the US.

University of Pittsburgh-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Pittsburgh, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

University of Pittsburgh, Medical Devices Deals, 2012 to YTD 2018 10

University of Pittsburgh, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

University of Pittsburgh, Pharmaceuticals & Healthcare, Deal Details 13

Venture Financing 13

Evolent Health Raises USD 101.3 Million In Series B Financing 13

Partnerships 15

Globin Solutions Enters into Licensing Agreement with University of Pittsburgh Innovation Institute 15

Immunovia Enters into Agreement with University of Pittsburgh 16

Aires Pharma Enters into Agreement with University of Pittsburgh 17

University of Pittsburgh and Bayer Form Research Collaboration Agreement 18

University of Pittsburgh Cancer Institute Enters into Contract with National Cancer Institute 19

American Gene Technologies Partners with University of Pittsburgh 20

NanoViricides Enters into Research Agreement with University of Pittsburgh 21

GeoVax Labs Enters into Research Agreement with University of Pittsburgh 22

Licensing Agreements 23

Inmune Bio Enters into Licensing Agreement with University of Pittsburgh 23

Koutif Therapeutics Enters into Licensing Agreement with University of Pittsburgh 24

XW Labs Enters into Licensing Agreement with University of Pittsburgh 25

BioTime Enters into Licensing Agreement with University of Pittsburgh Medical Center 26

NuvOx Pharma Enters into Licensing Agreement with University of Pittsburgh 27

Asana Medical Enters into Licensing Agreement with University of Pittsburgh 28

Oxis Biotech Amends Option Agreement with University of Pittsburgh to License Certain Patents 29

Oxis Biotech Amends Licensing Agreement with University of Pittsburgh 30

DiaVacs Enters into Licensing Agreement with University Of Pittsburgh 31

iBio Enters into Licensing Agreement with University of Pittsburgh 32

Stemline Therapeutics Enters Into Licensing Agreement With University of Pittsburgh For EphA2 33

Stemline Therapeutics Enters Into Licensing Agreement With University of Pittsburgh For SL-701 34

ImmunoCellular Enters Into Licensing Agreement With University of Pittsburgh 35

Equity Offering 36

Globin Solutions Spun Out from University of Pittsburgh Innovation Institute 36

Evolent Health Prices Secondary Offering of Class A Shares for USD159.4 Million 37

Acquisition 39

University of Pittsburgh Medical Acquires Family Hospice and Palliative Care 39

MedCare Equipment Acquires Great Lakes Home Healthcare Services From UPMC Hamot 40

University of Pittsburgh-Key Competitors 41

University of Pittsburgh-Key Employees 42

University of Pittsburgh-Locations And Subsidiaries 43

Head Office 43

Other Locations & Subsidiaries 43

Recent Developments 46

Government and Public Interest 46

Aug 30, 2018: Jewish Healthcare foundation approves over USD 1 million in grants 46

Aug 21, 2018: Pitt Doctor Gets Grant to Evaluate Self-Management Approach to Chronic Pain in HIV Patients 48

Jul 25, 2018: CurePSP supports four new studies through its venture grants program 49

Jul 02, 2018: Barone Gibbs and Collaborators Awarded USD 3.4 million from NIH to Study Sitting and Blood Pressure 50

Feb 27, 2018: Multiple Types of Delirium in the ICU Indicate High Risk for Long-Term Cognitive Decline, Study Finds 51

Jan 19, 2018: Researchers Analyze Big Data, Aim for Lung Disease Precision Treatment Improvement 52

Dec 20, 2017: Smartphone App Shows Promise Monitoring Chemotherapy Patients 54

Dec 13, 2017: IBBR Awarded NIH Grant to Investigate Body's T-Cell Mechanism of Attack 55

Nov 15, 2017: Wider sampling of tumor tissues may guide drug choice, improve outcomes 56

Nov 14, 2017: Shining a light on the nervous system to thwart disease 58

Oct 31, 2017: NIH establishes new research in social epigenomics to address health disparities 59

Sep 08, 2017: Identification of new protein function that activates the harmful protein dissolution in the cell 62

May 09, 2017: Precision medicine improves treatment outcomes for some pancreatic cancer patients 64

Other Significant Developments 65

Aug 15, 2018: Healthcare Innovators professional society reaches member goal of 33 top industry executives for nationwide council 65

Aug 15, 2018: 'BOOST-3' Trial Seeks to Improve Outcomes After Severe Traumatic Brain Injury 66

Appendix 68

Methodology 68

About GlobalData 68

Contact Us 68

Disclaimer 68


List Of Figure

List of Figures

University of Pittsburgh, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Pittsburgh, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

University of Pittsburgh, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

University of Pittsburgh, Pharmaceuticals & Healthcare, Key Facts 2

University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Pittsburgh, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Pittsburgh, Deals By Therapy Area, 2012 to YTD 2018 9

University of Pittsburgh, Medical Devices Deals, 2012 to YTD 2018 10

University of Pittsburgh, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Evolent Health Raises USD 101.3 Million In Series B Financing 13

Globin Solutions Enters into Licensing Agreement with University of Pittsburgh Innovation Institute 15

Immunovia Enters into Agreement with University of Pittsburgh 16

Aires Pharma Enters into Agreement with University of Pittsburgh 17

University of Pittsburgh and Bayer Form Research Collaboration Agreement 18

University of Pittsburgh Cancer Institute Enters into Contract with National Cancer Institute 19

American Gene Technologies Partners with University of Pittsburgh 20

NanoViricides Enters into Research Agreement with University of Pittsburgh 21

GeoVax Labs Enters into Research Agreement with University of Pittsburgh 22

Inmune Bio Enters into Licensing Agreement with University of Pittsburgh 23

Koutif Therapeutics Enters into Licensing Agreement with University of Pittsburgh 24

XW Labs Enters into Licensing Agreement with University of Pittsburgh 25

BioTime Enters into Licensing Agreement with University of Pittsburgh Medical Center 26

NuvOx Pharma Enters into Licensing Agreement with University of Pittsburgh 27

Asana Medical Enters into Licensing Agreement with University of Pittsburgh 28

Oxis Biotech Amends Option Agreement with University of Pittsburgh to License Certain Patents 29

Oxis Biotech Amends Licensing Agreement with University of Pittsburgh 30

DiaVacs Enters into Licensing Agreement with University Of Pittsburgh 31

iBio Enters into Licensing Agreement with University of Pittsburgh 32

Stemline Therapeutics Enters Into Licensing Agreement With University of Pittsburgh For EphA2 33

Stemline Therapeutics Enters Into Licensing Agreement With University of Pittsburgh For SL-701 34

ImmunoCellular Enters Into Licensing Agreement With University of Pittsburgh 35

Globin Solutions Spun Out from University of Pittsburgh Innovation Institute 36

Evolent Health Prices Secondary Offering of Class A Shares for USD159.4 Million 37

University of Pittsburgh Medical Acquires Family Hospice and Palliative Care 39

MedCare Equipment Acquires Great Lakes Home Healthcare Services From UPMC Hamot 40

University of Pittsburgh, Key Competitors 41

University of Pittsburgh, Key Employees 42

University of Pittsburgh, Other Locations 43

University of Pittsburgh, Subsidiaries 43

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

University of Pittsburgh, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.